Cognition and wellbeing in middle-aged early treated people with phenylketonuria: Preliminary results and methodological lessons

The first cohort of early-treated adults with phenylketonuria (PKU) is reaching middle-age and moving towards old age. We do not know if and how the effects of an aging brain may interact with the effect of PKU. This study compared wellbeing and cognition in 19 middle-aged adults with PKU (age 40+ m...

Full description

Bibliographic Details
Published in:	Molecular Genetics and Metabolism Reports
Main Authors:	Lucie Thomas, Lynne Aitkenhead, Karolina M. Stepien, Alison Woodall, Anita Macdonald, Cristina Romani
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	PKU Aging Cognition Wellbeing Quality of life
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214426924001137

Similar Items

Epidemiological aspects in phenylketonuria patients from a region in northwestern Romania
by: Alin Remus Iuhas, et al.
Published: (2022-06-01)

Age–related psychophysiological vulnerability to phenylalanine in phenylketonuria
by: Vincenzo eLeuzzi, et al.
Published: (2014-06-01)

Phenylketonuria: A Comprehensive Review of Pathophysiology, Diagnosis, and Management Strategies
by: Agata Konopka, et al.
Published: (2024-08-01)

Allelic phenotype prediction of phenylketonuria based on the machine learning method
by: Yang Fang, et al.
Published: (2023-03-01)

The exercising patient with phenylketonuria: Considerations and research recommendations
by: Ben Green
Published: (2025-01-01)

A policy analysis of the national phenylketonuria screening program in Iran
by: Alireza Heidari, et al.
Published: (2021-02-01)

Intelligence quotient scores among early-treated phenylketonuria patients: results from a systematic literature review
by: Fiona O’Sullivan, et al.
Published: (2025-06-01)

Incidence of Phenylketonuria in Southern Khorasan (2012- 2014): Short Communication
by: Zohre Saadatinasab, et al.
Published: (2015-10-01)

Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model
by: Ramon Diaz-Trelles, et al.
Published: (2022-09-01)

Promoting psychological well-being in women with phenylketonuria: Pregnancy-related stresses, coping strategies and supports
by: Rachel M. Roberts, et al.
Published: (2014-01-01)

Characteristics and outcomes of pregnancies among women with phenylketonuria from the NBS Connect registry
by: Aileen Kenneson, et al.
Published: (2024-06-01)

Patient and carer perceptions of video, telephone and in-person clinics for Phenylketonuria (PKU)
by: Hannah McBride, et al.
Published: (2024-08-01)

The complete European guidelines on phenylketonuria: diagnosis and treatment
by: A. M. J. van Wegberg, et al.
Published: (2017-10-01)

Motor Development Skills of 1- to 4-Year-Old Iranian Children with Early Treated Phenylketonuria
by: Firouzeh Sajedi, et al.
Published: (2014-03-01)

Biochemical evaluation of phenylketonuria (PKU): from diagnosis to treatment
by: Leticia Belmont-Martínez, et al.
Published: (2014-07-01)

Generation of fibroblast-derived induced pluripotent stem cell (iPSC) lines from two paediatric patients with phenylketonuria
by: Desi Veleva, et al.
Published: (2024-06-01)

Total choline intake and working memory performance in adults with phenylketonuria
by: Meriah S. Schoen, et al.
Published: (2023-07-01)

The Adult Phenylketonuria (PKU) Gut Microbiome
by: Viviana J. Mancilla, et al.
Published: (2021-03-01)

Phenylketonuria Patients’ and Their Caregivers’ Perception of the Pandemic Lockdown: The Results of a National Online Survey
by: Dariusz Walkowiak, et al.
Published: (2022-01-01)

Professional activity, gender and disease-related emotions: The impact on parents' experiences in caring for children with phenylketonuria
by: Dariusz Walkowiak, et al.
Published: (2023-09-01)

Development of an mRNA replacement therapy for phenylketonuria
by: Carlos G. Perez-Garcia, et al.
Published: (2022-06-01)

Molecular characterization of phenylketonuria patients from the North Region of Brazil: State of Pará
by: Pedro E. Bonfim‐Freitas, et al.
Published: (2023-10-01)

Determination of Physicochemical, Rheological, Microbiological and Sensory Properties of Low Protein Yoghurt Substitutes Produced for PKU (Phenylketonuria) Patients
by: Fatma Çoşkun, et al.
Published: (2023-11-01)

Identification of deep intronic variants of PAH in phenylketonuria using full-length gene sequencing
by: Chuan Zhang, et al.
Published: (2023-05-01)

Epidemiology of Phenylketonuria Disease in Jordan: Medical and Nutritional Challenges
by: Safwan Dababneh, et al.
Published: (2022-03-01)

Creatine Levels in Patients with Phenylketonuria and Mild Hyperphenylalaninemia: A Pilot Study
by: Elvira Verduci, et al.
Published: (2021-05-01)

Low bone mineralization in phenylketonuria may be due to undiagnosed metabolic acidosis
by: Valentina Rovelli, et al.
Published: (2023-09-01)

Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response
by: Priscila Nicolao Mazzola, et al.
Published: (2015-12-01)

Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation
by: Claire Cannet, et al.
Published: (2020-02-01)

The spectrum of phenylalanine hydroxylase variants and genotype–phenotype correlation in phenylketonuria patients in Gansu, China
by: Chuan Zhang, et al.
Published: (2023-04-01)

Vitamin B12 and Folate in Adherent and Non-Adherent Individuals with Phenylketonuria: A Cross-Sectional Study, Systematic Review, and Meta-Analysis
by: Kamila Bokayeva, et al.
Published: (2025-07-01)

Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice
by: Maximiliano L. Cacicedo, et al.
Published: (2022-10-01)

Classical phenylketonuria presenting as maternal PKU syndrome in the offspring of an intellectually normal woman
by: Malak Ali Alghamdi, et al.
Published: (2023-09-01)

Performance of the Egoo test for phenylalanine measurement in females with phenylketonuria
by: Meriah S. Schoen, et al.
Published: (2025-10-01)

The challenge of adults with phenylketonuria who have been lost to care; a single center's attempt to reach those diagnosed with PKU over 60 years of newborn screening
by: S. Sacharow, et al.
Published: (2024-09-01)

Docosahexaenoic acid supplementation in phenylketonuria: a systematic review
by: Manuel Alanís-Bernal, et al.
Published: (2025-10-01)

Health economic impact of patients with phenylketonuria (PKU) in France – A nationwide study of health insurance claims data
by: Jean-Baptiste Arnoux, et al.
Published: (2024-12-01)

Adherence to PKU guidelines among patients with phenylketonuria: A cross-sectional national multicenter survey-based study in Argentina, Brazil, and Mexico
by: Ana Chiesa, et al.
Published: (2024-03-01)

From PKU Online Lessons for Dietetics Students to the PKU Sandwiches Album
by: Klaudia Konikowska, et al.
Published: (2022-02-01)

Biochemical Evaluation of Phenylalanine Ammonia Lyase from Endemic Plant Cyathobasis fruticulosa (Bunge) Aellen. for the Dietary Treatment of Phenylketonuria
by: Seda Şirin, et al.
Published: (2016-01-01)